Novel Coronavirus (COVID-19)
About the COVID-19 novel Coronavirus
Follow the links below to find resources related to COVID-19 for all facilities, including the NETEC webinar series, PPE use and conservation guidance documents, education and training resources, preparedness resources, research on respiratory pathogens and airborne transmission, clinical guidance documents, documents on ambulatory PPE, and other research resources. Click here for items on COVID-19 and pediatrics. Scroll for the COVID-19 map, key updates, and new NETEC resources. You can go to the WHO COVID-19 pages and the CDC COVID-19 pages for additional resources.
New NETEC Resources:
Updates and Map
Find more information on Coronavirus on the Lancet's Coronavirus page. See updates on COVID-19 on the WHO Novel Coronavirus (COVID-19) page with Situation Reports and Disease Outbreak News, and see the updated Geographical distribution of COVID-19 cases within China and globally on the European Centre for Disease Prevention and Control page. Map below created by Johns Hopkins (if the map does not load below, you can view it on the Johns Hopkins page).
- On Feb. 27, 2020, the FDA approved the Janssen Biotech Inc./Johnson & Johnson COVID-19 one-shot vaccine for emergency use, allowing this third vaccine to roll out in the USA (FDA).
- On Feb. 15, 2020, the WHO listed the AstraZeneca/Oxford COVID-19 vaccine for emergency use, which allows it to roll out globally through COVAX (WHO).
- On Feb. 9, 2020, the FDA issued an Emergency Use Authorization (EUA) for bamlanivimab and etesevimab administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients (12-years-old+, weighing at least 40 kg) (FDA).
- New COVID-19 variants are circulating globally. Find out more from the CDC.
- Follow the number of vaccination doses distributed and administered in the USA on the CDC's dashboard. The Moderna developed vaccine was given FDA approval on Friday December 18, 2020 (FDA). The CDC signed the recommendation to use Pfizer’s vaccine on December 12, 2020 (CDC).
- The NIH COVID-19 Treatment Guidelines summarizes clinical data for treatment of COVID-19 (CDC).
- Development continues to advance on coronavirus vaccines with over two dozen in human trials. Follow the development of each with the Coronavirus Vaccine Tracker managed by The New York Times.
- On 31 December 2019 the WHO China Country Office was informed of cases of pneumonia of unknown etiology (unknown cause) in Wuhan City, China. A novel coronavirus (2019-nCoV) was identified by Chinese authorities on 7 January 2020 (WHO). On 11 February the name of the virus was announced as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and of the disease as coronavirus disease (COVID-19) (WHO).
CDC Novel Coronavirus Updates
Cases in the U.S....
Tue, 02 Mar 2021CDC COVID Data Tracker - Cases and Deaths by State
COVID-19 Contact Tracing Communications Toolkit for Health Depart...
Tue, 02 Mar 2021This toolkit will help health departments develop their communications with communities about COVID-19 contact tracing.
Understanding Viral Vector COVID-19 Vaccines...
Tue, 02 Mar 2021Viral vector vaccines are a type of vaccine likely to be approved for use for COVID-19 that work differently from the initially approved mRNA vaccines.